Product review of DrugPatentWatch (key advantages; introduction; contact details)
Jinfo Article
19th January 2018
By Scott Vine
Abstract
We carry out an in-depth product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs and patents and was founded by Yali Friedman, named one of the 100 most influential people in biotechnology. Part one of the review introduces the product and company behind it, along with its key advantages, competitors and how the product is likely to evolve.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (key advantages; introduction; contact details)
- Link to this page
- View printable version
Related articles:
- Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Wednesday, 24th January 2018 - Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Tuesday, 23rd January 2018 - Product review of DrugPatentWatch (sources - content & coverage)
Monday, 22nd January 2018
Related reports:
- Product review of DrugPatentWatch
Friday, 19th January 2018